Back to search
FDAFDA · Food and drugs·Recall number D-1046-2014

MaXtremeZEN capsules, 1 capsule per blister pack, Distributed by: P&A Enterprise, Buena Park, CA 90621, UPC 6 10079 52468 2.

Published February 5, 2014 · Recall initiated: November 18, 2013

Summary

FDA records drug Class I recall D-1046-2014, published February 5, 2014 and initiated November 18, 2013. Recalling firm: SS Wholesale Inc. dba Jobbers Wholesale; Status: Terminated; Reported quantity: 2,395 blister packs total for all products; Lot: Lot #: JBP-L-1270-70, Exp 12/16. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SS Wholesale Inc. dba Jobbers Wholesale
Distributor
CA
Lot
Lot #: JBP-L-1270-70, Exp 12/16
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MaXtremeZEN capsules, 1 capsule per blister pack, Distributed by: P&A Enterprise, Buena Park, CA 90621, UPC 6 10079 52468 2. recalled?

Yes. FDA published recall D-1046-2014 on February 5, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine. Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug. Dapoxetine is an active ingredient not approved

What should I do if I have this product?

Voluntary: Firm initiated · Press Release